MetroPlusHealth Adds Ophelia to Telehealth Network
08/11/2026
Ophelia Joins MetroPlusHealth's Telehealth Network for Opioid Use Disorder Treatment
What happened: MetroPlusHealth has added Ophelia, a virtual opioid use disorder (OUD) treatment provider, to its telehealth network. Through this partnership, MetroPlusHealth members can now be referred directly to Ophelia's clinicians for secure telehealth visits, including buprenorphine-based medication-assisted treatment, ongoing clinical support, and individualized recovery planning — all deliverable from home or another private location.
Why it matters: Opioid use disorder treatment access remains a persistent gap in many Medicaid and safety-net managed care networks, particularly for patients who face transportation, scheduling, or stigma-related barriers to in-person addiction treatment. Adding a dedicated virtual OUD provider expands MetroPlusHealth's behavioral health and substance use treatment capacity without requiring new brick-and-mortar contracting, and it gives referring providers — primary care, emergency department, and behavioral health clinicians alike — a faster, lower-friction pathway to get patients started on medication-assisted treatment. For network and care management teams, this is also a signal that MetroPlusHealth is actively expanding its telehealth-based specialty partnerships, which may inform future network adequacy and referral-pattern strategy.
What the provider should do: Providers treating MetroPlusHealth members with opioid use disorder should factor Ophelia into their referral strategy for medication-assisted treatment, particularly for patients facing access barriers to in-person care. From a credentialing perspective, providers should verify referral pathways, directory updates, and any payer-specific billing requirements associated with this new telehealth network partnership, since new network additions of this kind often carry their own referral and documentation requirements even when the referring provider's own contract is unchanged.